Advertisement
The Body: The Complete HIV/AIDS Resource Follow Us Follow Us on Facebook Follow Us on Twitter
Professionals >> Visit The Body PROThe Body en Espanol
Home Page for TheBody.com, the Complete HIV/AIDS Resource What's New About HIV Ask the Experts About HIV HIV/AIDS Blogs Connect With Others About HIV Just Diagnosed With HIV HIV Treatment HIV Prevention Living With HIV Personal Stories of People With HIV
HIV/AIDS Conferences
Upcoming Conferences

Feb. 22-23
Philadelphia, Pa.
MILES Training Program

March 5-8
Seattle, Wash.
CROI 2012: 19th Conference on Retroviruses and Opportunistic Infections

March 12-15
Minneapolis, Minn.
2012 National STD Prevention Conference

More upcoming HIV/AIDS meetings >>

Conference Calendar
2012
FEB. MARCH
APRIL MAY
JUNE JULY
AUG. SEP.
OCT. DEC.

The Body's Conference Coverage
ICAAC 2011
HIV/AIDS TREATMENT STRATEGIES: Sangamo's SB-728 HIV Gene Therapy Approach Still Looks Sexy, but Leaves More Questions Than Answers

DRUGS IN DEVELOPMENT: Ibalizumab Study Casts a Ray of Hope for HIV-Infected People With Extensive Drug Resistance

CLINICAL DEVELOPMENTS: ICAAC HIV Poster Roundup #1: Clinically Relevant Findings

CLINICAL DEVELOPMENTS: ICAAC HIV Poster Roundup #2: Clinically Relevant Findings

More from ICAAC 2011 >>

 

ICAAC 2010
HIV/AIDS TREATMENT STRATEGIES: Once-Daily "Extended" Formulation of Nevirapine Holds Up Well in 48-Week Study Results

DRUGS IN DEVELOPMENT: "Quad" Pill Continues to Impress in Week-48 Results; Cobicistat Moves Forward in Battle With Ritonavir

HIV/AIDS TREATMENT STRATEGIES: A Slice of Atazanavir, but Hold the Ritonavir: Switch to Unboosted Dose Still Effective After 120 Weeks, With Good Lipid Findings

COMPLICATIONS & COINFECTIONS: Even Among Long-Term HIV Nonprogressors, Some Signs of Heightened Cardiovascular Risk Exist, U.S. Study Finds

More from ICAAC 2010 >>
CROI 2011
HIV/AIDS TREATMENT STRATEGIES: Could MicroRNA Be the Next Great Frontier in HIV/AIDS Treatment -- and Prevention?

COMPLICATIONS & COINFECTIONS: The Slow Decline: An Update on Neurological Complications Among People With HIV

HIV/AIDS TREATMENT STRATEGIES: Zinc Fingers and Gene Therapies for HIV: Mimicking the Cured Berlin Patient?

HIV TREATMENT & HEALTH ISSUES: Studies in Post-Menopausal Women Reveal Potentially Higher Biological HIV Risk, as Well as Possible Tenofovir Concerns

More from CROI 2011 >>

 

AIDS 2010
HIV PREVENTION & TRANSMISSION: AIDS 2010: Study Finds Microbicide Containing HIV Drug Lowers Infection Risk in Women By 39%

DRUGS IN DEVELOPMENT: An Anti-Inflammation Antiretroviral? CCR5/CCR2 Antagonist TBR-652 Monotherapy Study Results

HIV/AIDS TREATMENT STRATEGIES: Protective Genes Play Crucial Role in Defense Against HIV

DEVELOPING WORLD: Where HIV Care Is a Rare and Precious Thing, 4,000 May Be About to Lose It

HIV PREVENTION & TRANSMISSION: Q&A: Drs. Salim and Quarraisha Abdool Karim, Breakthrough Microbicide Researchers

More from AIDS 2010 >>

 

Past Conference Coverage
Advertisement